Inoue T - Search Results

1

Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma.

Numakura K, Igarashi R, Takahashi M, Nara T, Kanda S, Saito M, Narita S, Inoue T, Niioka T, Miura M, Habuchi T. Numakura K, et al. Among authors: inoue t. Cancer Biol Ther. 2024 Dec 31;25(1):2312602. doi: 10.1080/15384047.2024.2312602. Epub 2024 Feb 7. Cancer Biol Ther. 2024. PMID: 38327067 Free PMC article.

2

Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder.

Nadaoka J, Horikawa Y, Saito M, Kumazawa T, Inoue T, Narita S, Yuasa T, Satoh S, Nishiyama H, Ogawa O, Tsuchiya N, Habuchi T. Nadaoka J, et al. Among authors: inoue t. Int J Cancer. 2008 Mar 15;122(6):1297-302. doi: 10.1002/ijc.23256. Int J Cancer. 2008. PMID: 18000826

3

Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma.

Tsuchiya N, Narita S, Inoue T, Hasunuma N, Numakura K, Horikawa Y, Satoh S, Notoya T, Fujishima N, Hatakeyama S, Ohyama C, Habuchi T. Tsuchiya N, et al. Among authors: inoue t. Anticancer Drugs. 2013 Mar;24(3):310-4. doi: 10.1097/CAD.0b013e32835c401c. Anticancer Drugs. 2013. PMID: 23237922 Clinical Trial.

4

Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.

Tsuchiya N, Narita S, Inoue T, Saito M, Numakura K, Huang M, Hatakeyama S, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T. Tsuchiya N, et al. Among authors: inoue t. BMC Cancer. 2013 Mar 25;13:150. doi: 10.1186/1471-2407-13-150. BMC Cancer. 2013. PMID: 23530598 Free PMC article.

5

Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma.

Tsuchiya N, Yuasa T, Maita S, Narita S, Inoue T, Numakura K, Saito M, Satoh S, Yonese J, Habuchi T. Tsuchiya N, et al. Among authors: inoue t. BMC Urol. 2014 Mar 11;14:26. doi: 10.1186/1471-2490-14-26. BMC Urol. 2014. PMID: 24612599 Free PMC article.

6

Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.

Kanda S, Tsuchiya N, Narita S, Inoue T, Huang M, Chiba S, Akihama S, Saito M, Numakura K, Tsuruta H, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T. Kanda S, et al. Among authors: inoue t. Int J Cancer. 2015 Jan 1;136(1):74-82. doi: 10.1002/ijc.28952. Epub 2014 May 20. Int J Cancer. 2015. PMID: 24803183

7

Characterization of clinical and genetic risk factors associated with dyslipidemia after kidney transplantation.

Numakura K, Kagaya H, Yamamoto R, Komine N, Saito M, Hiroshi T, Akihama S, Inoue T, Narita S, Tsuchiya N, Habuchi T, Niioka T, Miura M, Satoh S. Numakura K, et al. Among authors: inoue t. Dis Markers. 2015;2015:179434. doi: 10.1155/2015/179434. Epub 2015 Apr 6. Dis Markers. 2015. PMID: 25944971 Free PMC article.

8

Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib.

Numakura K, Tsuchiya N, Kagaya H, Takahashi M, Tsuruta H, Inoue T, Narita S, Huang M, Satoh S, Niioka T, Miura M, Habuchi T. Numakura K, et al. Among authors: inoue t. Anticancer Drugs. 2017 Jan;28(1):97-103. doi: 10.1097/CAD.0000000000000425. Anticancer Drugs. 2017. PMID: 27564227

9

Inverse relationship between insulin receptor expression and progression in renal cell carcinoma.

Takahashi M, Inoue T, Huang M, Numakura K, Tsuruta H, Saito M, Maeno A, Nakamura E, Narita S, Tsuchiya N, Habuchi T. Takahashi M, et al. Among authors: inoue t. Oncol Rep. 2017 May;37(5):2929-2941. doi: 10.3892/or.2017.5552. Epub 2017 Apr 5. Oncol Rep. 2017. PMID: 28393204 Free article.

10

Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma.

Igarashi R, Inoue T, Fujiyama N, Tsuchiya N, Numakura K, Kagaya H, Saito M, Narita S, Satoh S, Niioka T, Miura M, Habuchi T. Igarashi R, et al. Among authors: inoue t. Med Oncol. 2018 Mar 9;35(4):51. doi: 10.1007/s12032-018-1113-8. Med Oncol. 2018. PMID: 29524031 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,863 results

Search Page

Filters